Timber Pharmaceuticals Provides Business Update and Announces First Quarter 2021 Financial Results
Retrieved on:
Tuesday, May 11, 2021
The Company anticipates topline data readout in the third quarter of 2021 for the TMB-001 study.
Key Points:
- The Company anticipates topline data readout in the third quarter of 2021 for the TMB-001 study.
- The Company\'s investigational therapies have proven mechanisms-of-action backed by decades of clinical experience and well-established CMC (chemistry, manufacturing and control) and safety profiles.
- Prospective investors are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date of this press release.
- The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise.\n'